Michael R. McDonnell
CIK 1121897 · EVP, Chief Financial Officer · last filed 2026-07-10
Michael R. McDonnell is an EVP, Chief Financial Officer who has filed 58 SEC Form 4 insider transactions across 11 companies since 2007. The most recent filing, for MRNA, was dated Jul 10, 2026. Across all open-market trades the lifetime net is −$4.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $16.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$16.36M
11
58
-$4.37M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MRNA | Director | — | $55.85 | — | $0 | 1 | 2026-07-10 |
| MMSI | Director | 9,852 | $80.19 | $790.0K | -$330.4K | 6 | 2026-05-19 |
| BAX | Director | 14,647 | $24.70 | $361.9K | $0 | 2 | 2026-05-07 |
| BIIB | EVP, Chief Financial Officer | 25,712 | $207.09 | $5.32M | $0 | 16 | 2025-02-12 |
| IQV | EVP and CFO | 18,966 | $246.34 | $4.67M | -$3.08M | 8 | 2020-07-07 |
| Frontier Communications Parent, Inc. (FTR) Delisted | Director | — | — | — | $0 | 2 | 2019-04-02 |
| Q | EVP and CFO | 40,517 | $128.54 | $5.21M | $0 | 6 | 2017-07-07 |
| CATALYST HEALTH SOLUTIONS, INC. (CHSI) Delisted | Director | 8,500 | — | — | -$884.1K | 7 | 2012-06-05 |
| CATALYST HEALTH SOLUTIONS, INC. (HLEX) Delisted | Director | 4,000 | — | — | -$72.4K | 3 | 2008-08-27 |
| MCG CAPITAL CORP (MCGC) Delisted | EVP, CFO & COO | 338,200 | — | — | $0 | 2 | 2008-05-01 |
| MCG CAPITAL CORP (MCGCR) Delisted | EVP, CFO & COO | 170,700 | — | — | $0 | 1 | 2008-04-21 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-10 | MRNA | Grant (A) | — | $0 | EDGAR |
| 2026-05-19 | MMSI | Grant (A) | +3,457 | $0 | EDGAR |
| 2026-05-07 | BAX | Grant (A) | +12,836 | $0 | EDGAR |
| 2026-02-18 | BAX | Grant (A) | +1,811 | $0 | EDGAR |
| 2025-06-03 | MMSI | Sell (S) | −3,500 | -$330.4K | EDGAR |
| 2025-06-02 | MMSI | Notice (144) | −1,750 | -$165.4K | EDGAR |
| 2025-05-30 | MMSI | Notice (144) | −1,750 | -$165.0K | EDGAR |
| 2025-05-19 | MMSI | Grant (A) | +2,152 | $0 | EDGAR |
| 2025-02-12 | BIIB | Mixed | +1,886 | -$195.4K | EDGAR |
| 2025-02-10 | BIIB | Mixed | +3,049 | -$212.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.